Bangladesh is going to have its first ever positive news biotech industry as Oryx Bio-Tech in collaboration with China Biologic Products, a U.S. NASDAQ listed Biotech Company, has begun the construction of their Plasma Fractionation Plant in Block-II of Summit Technopolis in Bangabandhu Hi-Tech City, Kaliakoir.
With an investment of USD 300 million, the company’s plasma fractionation plant in Block II of Summit Technopolis will produce plasma derivatives, also known as Life Saving Therapeutics – hence making it the first biotech foreign direct investment (FDI) in Bangladesh. The industry will also have the capacity to process 1,200 tonnes of plasma annually.
Industry insiders say it’s a timely investment for Bangladesh’s healthcare research and service sector. This project, located in Kaliakoir of Gazipur, near the capital city, is expected to employ about 2,000 high-value jobs from the science and technology background.
State Minister for ICT Zunaid Ahmed Palak, MP, attended the groundbreaking event as the chief guest on Monday. He said, “The Oryx project will open an era of positive news biotech industry and open the door for other such hi-tech projects for Bangladesh.”
Chairman of Oryx Bio-Tech Kazi Shakil said, “The Oryx plant will produce Life Saving Therapeutics that are currently produced only in the most advanced countries of the world.”
Directors of Summit Group Fadiah Khan said, “Summit is welcoming hi-tech investors in Bangladesh, a regional hub in the near future that will open doors of opportunities to our tech-savvy youth. Bangladesh has shown its resilience with COVID management and we are here to support the nation to take next step of economic growth.”
NM Zeaul Alam, Senior Secretary, ICT Division and Hosne Ara Begum ndc, Managing Director (Secretary), Bangladesh Hi-Tech Park Authority (BHTPA), were present as the special guests. Among other distinguished guests present were MD of Summit Technopolis Abu Reza Khan.
Oryx Biotech Holdings, parent company of Oryx Bio-Tech Ltd., is a China-based biological product developer. With support of our technical partner, the NASDAQ USA-listed company namely China Biologic Products Holdings, Inc., which is the most technologically advanced and one of the largest Life Saving Therapeutics manufacturers in China.
Meanwhile, Summit Technopolis Limited, a Public Private Partnership (PPP), is the concessionaire for developing infrastructure for hi-tech industry comprising of Information Technology (IT), Information Technology Enabled Services (ITeS), bio-tech, non-polluting manufacturing assembly lines and precision engineering companies, in the 91 acres area in Bangabandhu Hi- Tech City, Kaliakoir. The company took lease under the provision to design, build, finance, own, operate and transfer to the government on completion of 60-year lease period.